References
- Ronnett BM, Shmookler BM, Diener-West M, Sugarbaker PH, Kurman RJ. Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women. Int J Gynecol Pathol 1997;16:1–9.
- Sugarbaker PH. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Eur J Surg Oncol 2001;27:239–43.
- Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221: 29–42.
- Elias DM, Ouellet JF. Intraperitoneal chemohyperthermia: rationale, technique, indications, and results. Surg Oncol Clin N Am 2001;10:915–33, xi.
- Ronnett BM, Yan H, Kurman RJ, Shmookler BM, Wu L, Sugarbaker PH. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer 2001;92:85–91.
- Yan H, Pestieau SR, Shmookler BM, Sugarbaker PH. Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation. Mod Pathol 2001;14:164–71.
- Esquivel J, Sugarbaker PH. Clinical presentation of the pseudomyxoma peritonei syndrome. Br J Surg 2000;87:1414–8.
- Zissin R, Gayer G, Kots E, Apter S, Peri M, Shapiro-Feinberg M. Imaging of mucocoele of the appendix with emphasis on the CT findings: a report of 10 cases. Clin Radiol 1999;54: 826–32.
- Sugarbaker PH. Cytoreductive surgery and perioperative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Tumori 2001;87:S3–S5.
- Zoetmulder FA, Sugarbaker PH. Patterns of failure following treatment of pseudomyxoma peritonei of appendiceal origin. Eur J Cancer 1996;32A:1727–33.
- Sugarbaker PH, Fernandez-Trigo V, Shamsa F. Clinical determinants of treatment failure in patients with pseudomyxoma peritonei. Cancer Treat Res 1996;81:121–32.
- Sebbag G, Yan H, Shmookler BM, Chang D, Sugarbaker PH. Results of treatment of 33 patients with peritoneal mesothelioma. BrJ Surg 2000;87: 1587–93.
- Sugarbaker PH, Yonemura Y. Palliation with a glimmer ofhope: management of resectable gastric cancer with peritoneal carcinomatosis. Hepatogastroenterology 2001;48:1238–47.
- Fann JI, Vierra M, Fisher D, Oberhelman HA, Jr, Cobb L. Pseudomyxoma peritonei. Surg Gynecol Obstet 1993;177:441–7.
- Pestieau SR, Wolk R, Sugarbaker PH. Congenital pleuroperitoneal communication in a patient with pseudomyxoma peritonei. J Surg Oncol 2000;73:174–8.
- Koizumi J, Noguchi H. Pseudomyxoma retroperitonei with spontaneous skin fistula. Abdom Imaging 1999;24:193–5.
- Al-Bozom IA. Extraperitoneal presentation of pseudomyxoma peritonei as a scrotal mass: case report and review of the literature. Ann Saudi Med 2000;20:197–99.
- Sugarbaker PH, Graves T, DeBruijn ED, Cunliffe WJ, Mullins RE, Hull WE, et al. Rationale for early postoperative intraperitoneal chemotherapy (EPIC) in patients with advanced gastrointestinal cancer. Cancer Res 1990;50:5790–4.